Redsense Medical AB (REDS) — Capital Reinvestment Ratio

Latest as of March 2025: 0.14x

Redsense Medical AB (REDS) has a Capital Reinvestment Ratio of 0.14x as of March 2025, meaning it reinvests 0% of its operating cash flow (Skr761.00K) in capital expenditures (Skr105.00K). Check Redsense Medical AB (REDS) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.14x
Capex / Operating Cash Flow

Operating Cash Flow

Skr761.00K
SEK

Capital Expenditures

Skr105.00K
SEK

Data as of

Mar 2025
Most recent filing

Redsense Medical AB Capital Reinvestment Ratio (2020–2020)

This chart tracks Redsense Medical AB's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see REDS cash generation efficiency.

Annual Capital Reinvestment Ratio for Redsense Medical AB (2020–2020)

Year-by-year Capital Reinvestment Ratio for Redsense Medical AB from 2020 to 2020. See REDS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2020 2.15x Skr17.23 Million Skr37.08 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow